1. Home
  2. COHN vs NNVC Comparison

COHN vs NNVC Comparison

Compare COHN & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHN
  • NNVC
  • Stock Information
  • Founded
  • COHN 1999
  • NNVC 2005
  • Country
  • COHN United States
  • NNVC United States
  • Employees
  • COHN N/A
  • NNVC N/A
  • Industry
  • COHN Investment Bankers/Brokers/Service
  • NNVC Biotechnology: Pharmaceutical Preparations
  • Sector
  • COHN Finance
  • NNVC Health Care
  • Exchange
  • COHN Nasdaq
  • NNVC Nasdaq
  • Market Cap
  • COHN 21.6M
  • NNVC 24.1M
  • IPO Year
  • COHN N/A
  • NNVC N/A
  • Fundamental
  • Price
  • COHN $12.59
  • NNVC $1.50
  • Analyst Decision
  • COHN
  • NNVC
  • Analyst Count
  • COHN 0
  • NNVC 0
  • Target Price
  • COHN N/A
  • NNVC N/A
  • AVG Volume (30 Days)
  • COHN 11.4K
  • NNVC 237.9K
  • Earning Date
  • COHN 07-31-2025
  • NNVC 09-26-2025
  • Dividend Yield
  • COHN 7.94%
  • NNVC N/A
  • EPS Growth
  • COHN 37.63
  • NNVC N/A
  • EPS
  • COHN 1.14
  • NNVC N/A
  • Revenue
  • COHN $133,173,000.00
  • NNVC N/A
  • Revenue This Year
  • COHN N/A
  • NNVC N/A
  • Revenue Next Year
  • COHN N/A
  • NNVC N/A
  • P/E Ratio
  • COHN $11.19
  • NNVC N/A
  • Revenue Growth
  • COHN 78.63
  • NNVC N/A
  • 52 Week Low
  • COHN $6.10
  • NNVC $0.94
  • 52 Week High
  • COHN $13.25
  • NNVC $2.34
  • Technical
  • Relative Strength Index (RSI)
  • COHN 69.24
  • NNVC 42.95
  • Support Level
  • COHN $11.02
  • NNVC $1.43
  • Resistance Level
  • COHN $12.89
  • NNVC $1.72
  • Average True Range (ATR)
  • COHN 0.66
  • NNVC 0.05
  • MACD
  • COHN 0.03
  • NNVC -0.02
  • Stochastic Oscillator
  • COHN 88.10
  • NNVC 24.14

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: